IGF2BP1 and neoplasm: Knockdown of IGF2BP1 expression level via applying a CRISPR/Cas9 genome editing system leading to upregulation of miR-4500 in GBM cells, and thereby suppressing tumor cell growth and metastasis to a large extent.